Digital subtraction angiography-guided pancreatic arterial infusion of GEMOX chemotherapy in advanced pancreatic adenocarcinoma: a phase II, open-label, randomized controlled trial comparing with intravenous chemotherapy.

Saved in:
Bibliographic Details
Title: Digital subtraction angiography-guided pancreatic arterial infusion of GEMOX chemotherapy in advanced pancreatic adenocarcinoma: a phase II, open-label, randomized controlled trial comparing with intravenous chemotherapy.
Authors: Huang C; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China., Cheng CS; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China., Shen Y; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. yehuash25@163.com.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. yehuash25@163.com., Chen H; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China., Lin J; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China., Hua Y; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China., Feng L; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China., Wu C; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China., Wang P; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China., Chen Z; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China., Meng Z; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. mengshca@fudan.edu.cn.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. mengshca@fudan.edu.cn.
Source: BMC cancer [BMC Cancer] 2024 Aug 02; Vol. 24 (1), pp. 941. Date of Electronic Publication: 2024 Aug 02.
Publication Type: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Comparative Study
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39095759
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Digital subtraction angiography-guided pancreatic arterial infusion of GEMOX chemotherapy in advanced pancreatic adenocarcinoma: a phase II, open-label, randomized controlled trial comparing with intravenous chemotherapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Huang+C%22">Huang C</searchLink>; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.<br /><searchLink fieldCode="AU" term="%22Cheng+CS%22">Cheng CS</searchLink>; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.<br /><searchLink fieldCode="AU" term="%22Shen+Y%22">Shen Y</searchLink>; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. yehuash25@163.com.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. yehuash25@163.com.<br /><searchLink fieldCode="AU" term="%22Chen+H%22">Chen H</searchLink>; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.<br /><searchLink fieldCode="AU" term="%22Lin+J%22">Lin J</searchLink>; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.<br /><searchLink fieldCode="AU" term="%22Hua+Y%22">Hua Y</searchLink>; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.<br /><searchLink fieldCode="AU" term="%22Feng+L%22">Feng L</searchLink>; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.<br /><searchLink fieldCode="AU" term="%22Wu+C%22">Wu C</searchLink>; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.<br /><searchLink fieldCode="AU" term="%22Wang+P%22">Wang P</searchLink>; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.<br /><searchLink fieldCode="AU" term="%22Chen+Z%22">Chen Z</searchLink>; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.<br /><searchLink fieldCode="AU" term="%22Meng+Z%22">Meng Z</searchLink>; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. mengshca@fudan.edu.cn.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. mengshca@fudan.edu.cn.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100967800%22">BMC cancer</searchLink> [BMC Cancer] 2024 Aug 02; Vol. 24 (1), pp. 941. <i>Date of Electronic Publication: </i>2024 Aug 02.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Comparative Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100967800 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1471-2407 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214712407%22">14712407 </searchLink><i>NLM ISO Abbreviation: </i>BMC Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39095759
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12885-024-12695-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 941
    Titles:
      – TitleFull: Digital subtraction angiography-guided pancreatic arterial infusion of GEMOX chemotherapy in advanced pancreatic adenocarcinoma: a phase II, open-label, randomized controlled trial comparing with intravenous chemotherapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Huang C
      – PersonEntity:
          Name:
            NameFull: Cheng CS
      – PersonEntity:
          Name:
            NameFull: Shen Y
      – PersonEntity:
          Name:
            NameFull: Chen H
      – PersonEntity:
          Name:
            NameFull: Lin J
      – PersonEntity:
          Name:
            NameFull: Hua Y
      – PersonEntity:
          Name:
            NameFull: Feng L
      – PersonEntity:
          Name:
            NameFull: Wu C
      – PersonEntity:
          Name:
            NameFull: Wang P
      – PersonEntity:
          Name:
            NameFull: Chen Z
      – PersonEntity:
          Name:
            NameFull: Meng Z
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 08
              Text: 2024 Aug 02
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1471-2407
          Numbering:
            – Type: volume
              Value: 24
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: BMC cancer
              Type: main
ResultId 1